18
Participants
Start Date
January 31, 2013
Primary Completion Date
February 28, 2014
Study Completion Date
March 31, 2015
40 mg MMC in 40 mL TC-3.
A reverse thermal biodegradable gel (TC-3) (low viscosity at 5°C gel appearance at body temperature) for drug retention in the urinary bladder.
80 mg MMC in 40 mL TC-3.
A reverse thermal biodegradable gel (TC-3) (low viscosity at 5°C gel appearance at body temperature) for drug retention in the urinary bladder.
Rajiv Gandhi Cancer Institute & Research Center, Delhi
UroGen Pharma Ltd.
INDUSTRY